MRKR

Marker Therapeutics, Inc. - Common Stock (MRKR)

About Marker Therapeutics, Inc. - Common Stock (MRKR)

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Details

Daily high

$1.25

Daily low

$1.12

Price at open

52 Week High

$2.46

52 Week Low

$0.81

Market cap

19.0M

Dividend yield

0.00%

Volume

156

Avg. volume

44,999

P/E ratio

-1.69

Marker Therapeutics, Inc. - Common Stock News